Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.
Title
Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.
Creator
Dluzen Dean E; McDermott Janet L
Publisher
Annals of the New York Academy of Sciences
Date
2002
2002-06
Description
In Part 1 of this report, we review data on the effects of estrogen (E), the anti-E tamoxifen (TMX), and testosterone (T) on methamphetamine (METH)-induced neurotoxicity in female and male CD-1 mice. Treatment of gonadectomized females with a physiological regimen of E significantly diminished the amount of striatal dopamine (DA) depletion to METH compared with non-E-treated mice. If these
Subject
*Neurotoxins; *Sex Characteristics; Animals; Biological; Estrogen Antagonists/*pharmacology; Estrogens/*physiology; Female; Humans; Male; Methamphetamine/*toxicity; Mice; Models; Tamoxifen/pharmacology; Testosterone/pharmacology
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Citation
Dluzen Dean E; McDermott Janet L, “Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.,” NEOMED Bibliography Database, accessed January 18, 2025, https://neomed.omeka.net/items/show/4488.